January 2016 – Policy & Medicine

ProPublica HIPAA Helper or HIPAA Wall of Shame

Another Transparency Threat – Health Education Exchanges and Medical Identity Theft

FDA CDER Update 2016

Senators Wyden and Grassley Request Public Comments on Gilead Pricing

CMS Final Rule on Covered Outpatient Drugs

Office of Management and Budget To Revise Fraud Rules by Spring

Improving Regulatory Transparency for New Medical Therapies Act

CME Saves in Overall Healthcare Cost

Washington, D.C. Changes Pharmaceutical Detailer License Requirements

Problems Abound with Ohio Drug Price Ballot Petition